First-in-Human study of KLA578-1 for injection in healthy volunteers
This trial tests a new investigational drug for the first time in people. It will study how the drug is processed by the body in healthy volunteers. If you are a generally healthy adult, you may be able to help with this important early research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are a healthy volunteer, with no major medical conditions
- Your body mass index (BMI) is between 19 and 26
- Men weigh at least 50 kg (about 110 lbs) and women at least 45 kg (about 99 lbs)
- You are not taking any prescription or over-the-counter medications
- You do not smoke heavily (no more than 3 cigarettes per day) and do not abuse alcohol or drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.
This study tests a new drug called KLA478 for the first time in humans. It is looking for healthy volunteers to see how the drug affects the body and how safe it is.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new drug called KLA318-2 in healthy volunteers to see how it is processed by the body and how safe it is. It is a first-in-human trial, so it helps find the right dose and check for any side effects.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.